β-Glucans in standardized allergen extracts

Abstract

Background: Allergen extracts contain variable quantities of bacterial endotoxin. Recent studies have suggested that (1→3)-β-D-glucans (β-glucans), also microbial cell wall components, may have adjuvant properties that could affect allergen immunotherapy.

Objective: To determine the quantities of β-glucans in standardized allergen extracts.

Materials and Methods : Ninety-four lots of 13 standardized allergen extracts were tested for β-glucan content by Glucatell assay, and for endotoxin content by a specific, chromogenic formulation of the Limulus amebocyte lysate test.

Results: Standardized allergen extracts contain variable quantities of endotoxins and β-glucans. As in our previous work, endotoxin activity was greatest in cat pelt and Dermatophagoides farinae, and least in the pollens. There was no correlation between endotoxin and β-glucan levels (r = 0.1887; P = 0.07). β-Glucan content was highest for grass pollen (median content, 10.6 ng/ml; range, 0.4—41.8 ng/ml), ragweed pollen (32.9 ng/ml; range, 6.5—41.2 ng/ml), and cat pelt (25.5 ng/ml; range, 16.7—41.1 ng/ml), and lowest for cat hair (4.9 ng/ml; range, 1.2—10.3 ng/ml), D. farinae (1.2 ng/ml; range, 0.4—5.2 ng/ml) and Dermatophagoides pteronyssinus (1.8 ng/ml; range, 0.4—6.7 ng/ml).

Conclusions: β-Glucans are present in standardized allergen extracts. The effects of these quantities of β-glucans on allergen immunotherapy and allergen skin testing require further study.

Keywords

β-Glucan endotoxin allergen immunotherapy allergen extracts allergen standardization

References

Liu AH Endotoxin exposure in allergy and asthma: reconciling a paradox. J Allergy Clin Immunol 2002; 109: 379—392.

Michel O. Role of lipopolysaccharide (LPS) in asthma and other pulmonary conditions . J Endotoxin Res 2003; 9: 293—300.

Instanes C. , Ormstad H. , Rydjord B. , Wiker HG , Hetland G. Mould extracts increase the allergic response to ovalbumin in mice . Clin Exp Allergy 2004; 34: 1634—1641.

Ormstad H. , Groeng EC , Lovik M. , Hetland G. The fungal cell wall component beta-1,3-glucan has an adjuvant effect on the allergic response to ovalbumin in mice. J Toxicol Environ Health A 2000; 61: 55—67.

Wan GH , Li CS , Guo SP , Rylander R. , Lin RH An airborne mold-derived product, beta-1,3-D-glucan, potentiates airway allergic responses. Eur J Immunol 1999; 29: 2491—2497.

Gehring U. , Douwes J. , Doekes G. et al. Beta-(1→3)-glucan in house dust of German homes: housing characteristics, occupant behavior, and relations with endotoxins, allergens, and molds. Environ Health Perspect 2001; 109: 139—144.

Douwes J. , Zuidhof A. , Doekes G. et al. (1→3)-beta-D-glucan and endotoxin in house dust and peak flow variability in children. Am J Respir Crit Care Med 2000; 162: 1348—1354.

Rylander R. , Fogelmark B. , McWilliam A. , Currie A. (1→3)-beta-D-glucan may contribute to pollen sensitivity. Clin Exp Immunol 1999; 115: 383—384.

Rylander R. , Holt PG (1→3)-beta-D-glucan and endotoxin modulate immune response to inhaled allergen. Mediators Inflamm 1998; 7: 105—110.

10.

Thorn J. , Rylander R. Airways inflammation and glucan in a rowhouse area. Am J Respir Crit Care Med 1998; 157: 1798—1803.

11.

Murata Y. , Shimamura T. , Tagami T. , Takatsuki F. , Hamuro J. The skewing to Th1 induced by lentinan is directed through the distinctive cytokine production by macrophages with elevated intracellular glutathione content. Int Immunopharmacol 2002; 2: 673—689.

12.

Inoue A. , Kodama N. , Nanba H. Effect of maitake (Grifola frondosa) D-fraction on the control of the T lymph node Th-1/Th-2 proportion. Biol Pharm Bull 2002; 25: 536—540.

13.

Suzuki Y. , Adachi Y. , Ohno N. , Yadomae T. Th1/Th2-Balancing immunomodulating activity of gel-forming (1→3)-beta-glucans from fungi. Biol Pharm Bull 2001; 24: 811—819.

14.

Fogelmark B. , Thorn J. , Rylander R. Inhalation of (1→3)-beta-Dglucan causes airway eosinophilia. Mediators Inflamm 2001 ; 10: 13—19.

15.

Trivedi B. , Valerio C. , Slater JE Endotoxin content of standardized allergen vaccines. J Allergy Clin Immunol 2003; 111: 777—783.

16.

Bernstein DI , Wanner M. , Borish L. , Liss GM Twelve-year survey of fatal reactions to allergen injections and skin testing: 1990—2001 . J Allergy Clin Immunol 2004; 113: 1129—1136.

17.

Takaki Y. , Seki N. , Kawabata SS , Iwanaga S. , Muta T. Duplicated binding sites for (1→3)-beta-D-glucan in the horseshoe crab coagulation factor G: implications for a molecular basis of the pattern recognition in innate immunity. J Biol Chem 2002; 277: 14281—14287.

18.

Odabasi Z. , Mattiuzzi G. , Estey E. et al. Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome. Clin Infect Dis 2004; 39: 199—205.

19.

Tanaka S. , Aketagawa J. , Takahashi S. , Shibata Y. , Tsumuraya Y. , Hashimoto Y. Activation of a Limulus coagulation factor G by (1→3)-beta-D-glucans . Carbohydr Res 1991; 218: 167—174.

20.

Wolff SM Biological effects of bacterial endotoxins in man. J Infect Dis 1973; 128: 259—264.

21.

Miller MA , Hjelle JT Endotoxins and their clinical significance. In: Prior RB. (ed) Clinical applications of the Limulus amoebocyte lysate test. Boston, MA: CRC Press , 1990; 1—14.

22.

Guideline on the validation of the Limulus Amebocyte Lysate Test as an End-Product Endotoxin Test for Human and Animal Parenteral Drugs, Biological Products and Medical Devices. Rockville, MD : FDA, 1987 @#x3C;www.fda.gov/Cber/gdlns/lal.pdf>.

23.

Siraganian RP , Baer H. , Hochstein HD , May JC Allergenic and biologic activity of commercial preparations of house dust extract. J Allergy Clin Immunol 1979; 64: 526—533.

24.

Smith TF , Morrison DC Lack of interference in skin tests by endotoxin in allergen extracts . Ann Allergy 1986; 57; 410—412.

25.

Valerio C. , Arlian LG , Slater JE Bacterial 16S ribosomal DNA sequences isolated from house dust mites . J Allergy Clin Immunol 2005; 115: S163.

26.

Nagasawa K. , Yano T. , Kitabayashi G. et al. Experimental proof of contamination of blood components by (1→3)-beta-D-glucan caused by filtration with cellulose filters in the manufacturing process. J Artif Organs 2003; 6: 49—54.

27.

Bell S. , Goldman VM , Bistrian BR , Arnold AH , Ostroff G. , Forse RA Effect of beta-glucan from oats and yeast on serum lipids. Crit Rev Food Sci Nutr 1999; 39: 189—202.

28.

Hong F. , Yan J. , Baran JT et al. Mechanism by which orally administered beta-1,3-glucans enhance the tumoricidal activity of antitumor monoclonal antibodies in murine tumor models. J Immunol 2004; 173: 797—806.

29.

Beijer L. , Thorn J. , Rylander R. Effects after inhalation of (1→3)-beta-D-glucan and relation to mould exposure in the home. Mediators Inflamm 2002 ; 11: 1-53.

30.

Thorn J. , Beijer L. , Rylander R. Effects after inhalation of (1→3)-beta-D-glucan in healthy humans . Mediators Inflamm 2001; 10: 173—178.

31.

Kawayama T. , Fujiki R. , Honda J. , Rikimaru T. , Aizawa H. High concentration of (1→3)-beta-D-glucan in BAL fluid in patients with acute eosinophilic pneumonia. Chest 2003; 123: 1302—1307.

32.

Beijer L. , Rylander R. (1→3)-beta-D-Glucan does not induce acute inflammation after nasal deposition . Mediators Inflamm 2005; 2005 (1): 50—52.

33.

Ohata A. , Usami M. , Horiuchi T. , Nagasawa K. , Kinoshita K. Release of (1→3)-beta-D-glucan from depth-type membrane filters and their in vitro effects on proinflammatory cytokine production. Artif Organs 2003; 27: 728—735.

34.

Usami M. , Ohata A. , Horiuchi T. , Nagasawa K. , Wakabayashi T. , Tanaka S. Positive (1→3)-beta-D-glucan in blood components and release of (1→3)-beta-D-glucan from depth-type membrane filters for blood processing . Transfusion 2002; 42: 1189—1195.

35.

Yan J. , Vetvicka V. , Xia Y. et al. Beta-glucan, a `specific' biologic response modifier that uses antibodies to target tumors for cytotoxic recognition by leukocyte complement receptor type 3 (CD11b/CD18). J Immunol 1999 ; 163: 3045—3052.

36.

Hong F. , Hansen RD , Yan J. et al. Beta-glucan functions as an adjuvant for monoclonal antibody immunotherapy by recruiting tumoricidal granulocytes as killer cells. Cancer Res 2003; 63: 9023—9031.

37.

Creticos PS , Van Metre TE , Mardiney MR , Rosenberg GL , Norman PS , Adkinson Jr NF. Dose response of IgE and IgG antibodies during ragweed immunotherapy. J Allergy Clin Immunol 1984; 73: 94—104.

38.

Francis JN , Till SJ , Durham SR Induction of IL-10+CD4+CD25+ T cells by grass pollen immunotherapy . J Allergy Clin Immunol 2003; 111: 1255—1261.

39.

Wachholz PA , Nouri-Aria KT , Wilson DR et al. Grass pollen immunotherapy for hayfever is associated with increases in local nasal but not peripheral Th1: Th2 cytokine ratios. Immunology 2002; 105: 56—62.

40.

Wilson DR , Nouri-Aria KT , Walker SM et al. Grass pollen immunotherapy: symptomatic improvement correlates with reductions in eosinophils and IL-5 mRNA expression in the nasal mucosa during the pollen season. J Allergy Clin Immunol 2001; 107: 971—976.

41.

Lowell FC , Franklin W. A double-blind study of the effectiveness and specificity of injection therapy in ragweed hay fever. N Engl J Med 1965; 273: 675—679.

42.

Hunt KJ , Valentine MD , Sobotka AK , Benton AW , Amodio FJ , Lichtenstein LM A controlled trial of immunotherapy in insect hypersensitivity. N Engl J Med 1978; 299: 157—161.

43.

Abramson MJ , Puy RM , Weiner JM Is allergen immunotherapy effective in asthma? A meta-analysis of randomized controlled trials. Am J Respir Crit Care Med 1995; 151: 969—974.

44.

Durham SR , Walker SM , Varga EM et al. Long-term clinical efficacy of grass-pollen immunotherapy. N Engl J Med 1999; 341: 468—475.

45.

Bousquet J. , Lockey R. , Malling HJ Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper. J Allergy Clin Immunol 1998; 102: 558—562.

46.

Nelson HS Preparing and mixing allergen vaccines. In: Lockey RF , Bukantz SC. (eds) Allergens and Allergen Immunotherapy. New York : Marcel Dekker, 1999; 401—422.